FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre.

Smejkal, P; Brabec, P; Matyskova, M; Bulikova, A; Slechtova, M; Kissova, J; Chlupova, G; Muzik, J; Penka, M

Smejkal, P; Brabec, P; Matyskova, M; Bulikova, A; Slechtova, M; Kissova, J; Chlupova, G; Muzik, J; Penka, M.

Affiliation

Smejkal P; Department of Clinical Haematology, Faculty Hospital and Medical School of Masaryk University, Brno, Czech Republic. psmejkal@fnbrno.cz

Haemophilia ; 15(3): 743-51, 2009 May.

Article in En | MEDLINE | ID: mdl-19432925

Subject(s)

Blood Coagulation Factor Inhibitors/therapeutic use; Blood Coagulation Factors/therapeutic use; Factor VIII/therapeutic use; Hemarthrosis/drug therapy; Hemophilia A/drug therapy; Hemostasis/drug effects; Adult; Blood Coagulation Factor Inhibitors/antagonists & inhibitors; Blood Coagulation Factors/economics; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Factor VIII/economics; Hemarthrosis/economics; Hemarthrosis/prevention & control; Hemophilia A/complications; Hemophilia A/economics; Home Care Services; Humans; Male; Middle Aged; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Factors / Factor VIII / Blood Coagulation Factor Inhibitors / Hemarthrosis / Hemophilia A / Hemostasis Type of study: Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Haemophilia Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google